Pharmacogenetics: the slow, the rapid, and the ultrarapid.

Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

I-33: Pharmacogenetics of Reproductive Medicine

Adverse drug reactions (ADRs) are a major problem in drug therapy and drug development. Inter-individual genetic differences can have significant roles in determining an individual’s susceptibility to ADRs. The rapid development of techniques in the area of genome analysis has put the scientific community in a power position and facilitated identification of new pharmacogenomic biomarkers that ...

Inm-5: Outcomes of Human Vitrified Embryos Transfer

The techniques of cryopreservation let embryos which cannot be immediately transferred to the patient be stored for future use. The first successful pregnancy after transfer of cryopreserved human embryos was described in 1983 by Trounson et al. and the first birth after cryopreservation was later reported in 1984 by Zeilmaker et al.). The technique has rapidly been applied in most in-vitro fer...

Single and Repeated Ultra–Rapid Detoxification Prevents Cognitive Impairment in Morphine Addicted Rats: A Privilege for Single Detoxification

Background: Opioids have been shown to affect learning and memory processes. Different protocols of morphine withdrawal can substantially vary in their success to prevent opioid induced impairments of cognitive performance. In the present study, we report the effects of single and repetitive ultra-rapid detoxification (URD) on spatial learning and memory in morphine addicted rats. Methods: Morp...